Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Forty Seven Inc. to Present at Morgan St...||09/03/19|
|MENLO PARK, Calif., Sept. 03, 2019 -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to act...|
|Forty Seven, Inc. Granted Fast Track Des...||09/03/19|
|Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, toda...|
|Date||2019-08-13 (BMO)||Est. (EPS/Rev.)||($0.72)/ 0|
|Actual (EPS/Rev.)||$-0.74/||EPS (TTM)||0|